Florida Medical Space
 Game Changers  
    Volume V, Issue 46 | Nov. 18, 2016  
South Florida Healthcare Professionals on the Move:  
Promotions, Achievements, Engagements & Accolades
From the publisher of FHIweekly,  Specialty Focus & FloridaHealthIndustry.com

Current Events 

SFMGMA presents

End of Year Networking Event

12/1/16 | 6-8 pm

Martini Bar at Gulfstream
Hallandale Beach

Register/Learn More>>

PBCMS presents
2016 Starfish & Snowflake Gala
Sat., 12/3/16 | 6:30-10:30 pm
Kravis Center | WPB

Register/Learn More>>

The Healthcare Roundtable presents
Bundled Payments

Tues., 12/6/16 | 7:30-9:30 am

 Ft. Lauderdale

Register/Learn More>>

Current Events 

SFHEF presents

Holiday Party

12/8/16 | 5:30-8:30 pm

Brimstone Woodfire Grill
Pembroke Pines

Register/Learn More>>

Beit David Highland Lakes Shul presents

Health and Wellness Fair

1/22/17 | 10 am - 4 pm


This is a great opportunity for your business to elevate its brand, reach new clients and enjoy valuable, quality exposure in a multi-disciplined health care environment.

Learn More>>
Have You Completed Your Required CME Hours?

Sat., 12/10/16 | 9 am - 1:15 pm

Pullman Miami Hotel

5800 Blue Lagoon Drive Miami, FL  33126

Learn More>>
Do You Know a Healthcare Game Changer?
Publisher of :

Week in Review, Specialty Focus,
Updates in Pediatrics,
FHIweekly & Game Changers

Delray Medical Center Offers Innovative Heart Stent for Patients with Coronary Artery Disease

The recently FDA approved fully dissolving stent disappears after the treated
artery is healed

Delray Medical Center is one of only two hospitals in South Florida to commercially utilize the Abbott Absorb bioresorbable vascular scaffold in the treatment of coronary artery disease. The innovative device is inserted into a patient's clogged artery to keep it open and restore blood flow, and then gradually disappears in about three years. It is made of naturally dissolving material and is designed to reduce the risk of future blockages that can occur with traditional metal stents.
With the addition of this new treatment option, Delray Medical Center offers hope to those suffering from a heart condition that affects 15 million people in the United States and is a leading cause of death worldwide. While metal stents are permanent implants and can restrict vessel motion, the Absorb stent is made of a dissolving polymer, similar to dissolving sutures, allowing the artery to pulse and flex naturally.
"The introduction of this groundbreaking device marks the next generation of interventional cardiology," said Mark Bryan, CEO. "We are proud to be one of only seven hospitals in the state to offer this technology."

Read More>>
Vitale Whistle Blower Defense  
In Brief 
Miami based Gastro Health Continues to Grow
Dr. Enrique Hernandez-Sanchez, Pediatric Gastroenterologist, has joined the Wellington office. Dr. Hernandez has been with Gastro Health since 2013 and currently sees patients at the Gastro Health, Boca Raton pediatric center. Dr. Hernandez looks forward to expanding pediatric services at the new Wellington location.

CareCloud raises $31.5 million to compete in changing healthcare market

Nancy Dahlberg | Miami Herald

CareCloud, a Miami-based management platform for high-growth medical groups, announced Tuesday it has raised $31.5 million to finance its continued growth. Investors include a diversified financial services leader, The PNC Financial Services Group, and commerce technology giant First Data Corporation. Blue Cloud Ventures joined as a new investor and led the round.

With this capital injection, CareCloud has raised about $102 million since its founding in 2009.

Telemedicine startup MDLIVE taps new CEO

One of South Florida's fastest-growing telehealth companies is making some big C-suite changes. Based in Fort Lauderdale, MDLIVE has appointed Scott Decker to replace CEO Randy Parker, who will become Chief Business Development Officer. Decker has more than 30 years of experience as a health information technology executive.

Read More>>

Clinical trial provides BRCA testing at no charge for women and men with a certain type of breast cancer

The Ft. Lauderdale based Holy Cross Hospital cancer research program announced that it has a clinical trial that provides BRCA testing at no charge for women and men with a certain type of breast cancer. The trial is called the Brocade 3 Study. For BRCA-positive patients the clinical trial involves an investigational medication given along with standard of care treatment.
The study is being conducted by Leonard Seigel, MD at the Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital. For more information contact the study nurse, Eileen Georgi at 954-267-7748 or click HERE to learn more.

Inside FloridaHealthIndustry.com



Compliance Update


Healthcare Headlines    FHI logo cropped small version


Last  Word


Medicare Dispatch